Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akitsu Hotta

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
Journal of Neuromuscular Diseases|November 19, 2016
Genome Editing Gene Therapy for Duchenne Muscular DystrophyAkitsu Hotta
Annual Review of Genetics|September 26, 2015
From Genomics to Gene Therapy: Induced Pluripotent Stem Cells Meet Genome EditingAkitsu Hotta, Shinya Yamanaka
Journal of Cellular Biochemistry|September 6, 2008
Retroviral vector silencing during iPS cell induction: an epigenetic beacon that signals distinct pluripotent statesAkitsu Hotta, James Ellis
Cell Stem Cell|November 3, 2023
Hiding from allogeneic NK cells and macrophages by a synthetic receptorAkitsu Hotta, Joseph Lee
Methods in Molecular Biology (Clifton, N.J.)|November 18, 2022
Preparation of NanoMEDIC Extracellular Vesicles to Deliver CRISPR-Cas9 Ribonucleoproteins for Genomic Exon SkippingKei Watanabe, Peter Gee, Akitsu Hotta
Clinical Calcium|February 25, 2017
[Advances in genome editing technologies for treating muscular dystrophy.]Yukimasa Makita, Hiroyuki Hozumi, Akitsu Hotta
International Journal of Molecular Sciences|October 27, 2015
Minimizing off-Target Mutagenesis Risks Caused by Programmable NucleasesKentaro Ishida, Peter Gee, Akitsu Hotta
Cell|October 10, 2007
Retrovirus silencing by an epigenetic TRIMJames Ellis, Akitsu Hotta, Mojgan Rastegar
Stem Cells International|June 14, 2017
Cellular Reprogramming, Genome Editing, and Alternative CRISPR Cas9 Technologies for Precise Gene Therapy of Duchenne Muscular DystrophyPeter Gee, Huaigeng Xu, Akitsu Hotta
Development, Growth & Differentiation|December 17, 2013
Genetic correction using engineered nucleases for gene therapy applicationsHongmei Lisa Li, Takao Nakano, Akitsu Hotta
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
Journal of Neuromuscular Diseases|November 19, 2016
Genome Editing Gene Therapy for Duchenne Muscular DystrophyAkitsu Hotta
Annual Review of Genetics|September 26, 2015
From Genomics to Gene Therapy: Induced Pluripotent Stem Cells Meet Genome EditingAkitsu Hotta, Shinya Yamanaka
Journal of Cellular Biochemistry|September 6, 2008
Retroviral vector silencing during iPS cell induction: an epigenetic beacon that signals distinct pluripotent statesAkitsu Hotta, James Ellis
Cell Stem Cell|November 3, 2023
Hiding from allogeneic NK cells and macrophages by a synthetic receptorAkitsu Hotta, Joseph Lee
Methods in Molecular Biology (Clifton, N.J.)|November 18, 2022
Preparation of NanoMEDIC Extracellular Vesicles to Deliver CRISPR-Cas9 Ribonucleoproteins for Genomic Exon SkippingKei Watanabe, Peter Gee, Akitsu Hotta
Clinical Calcium|February 25, 2017
[Advances in genome editing technologies for treating muscular dystrophy.]Yukimasa Makita, Hiroyuki Hozumi, Akitsu Hotta
International Journal of Molecular Sciences|October 27, 2015
Minimizing off-Target Mutagenesis Risks Caused by Programmable NucleasesKentaro Ishida, Peter Gee, Akitsu Hotta
Cell|October 10, 2007
Retrovirus silencing by an epigenetic TRIMJames Ellis, Akitsu Hotta, Mojgan Rastegar
Stem Cells International|June 14, 2017
Cellular Reprogramming, Genome Editing, and Alternative CRISPR Cas9 Technologies for Precise Gene Therapy of Duchenne Muscular DystrophyPeter Gee, Huaigeng Xu, Akitsu Hotta
Development, Growth & Differentiation|December 17, 2013
Genetic correction using engineered nucleases for gene therapy applicationsHongmei Lisa Li, Takao Nakano, Akitsu Hotta
Pageof 10